Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2021 3
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 and acute pancreatitis: A systematic review.
Babajide OI, Ogbon EO, Adelodun A, Agbalajobi O, Ogunsesan Y. Babajide OI, et al. Among authors: ogunsesan y. JGH Open. 2022 Apr 14;6(4):231-235. doi: 10.1002/jgh3.12729. eCollection 2022 Apr. JGH Open. 2022. PMID: 35475200 Free PMC article. Review.
Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience.
Mohan M, Rein LE, Thalambedu N, Ogunsesan Y, Hussain M, Sethi J, Khan F, Gundarlapalli S, Yarlagadda L, Dhakal B, Price M, Shirey M, Warner D, Thanendrarajan S, Janz S, Radhakrishnan SV, Al Hadidi S, Szabo A, D'Souza A, Zangari M, van Rhee F, Chhabra S, Schinke C. Mohan M, et al. Among authors: ogunsesan y. Am J Hematol. 2022 Dec;97(12):E451-E453. doi: 10.1002/ajh.26728. Epub 2022 Sep 24. Am J Hematol. 2022. PMID: 36097868 Free article. No abstract available.
Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma.
Yarlagadda L, Gundarlapalli S, Parikh R, Landes RD, Kottarathara M, Ogunsesan Y, Hoque S, Mitma AA, Bailey C, Hill KM, Thanendrarajan S, Graziutti M, Mohan M, Zangari M, van Rhee F, Tricot G, Schinke C. Yarlagadda L, et al. Among authors: ogunsesan y. Cancers (Basel). 2021 Aug 10;13(16):4019. doi: 10.3390/cancers13164019. Cancers (Basel). 2021. PMID: 34439174 Free PMC article.
Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy.
Al Hadidi S, Szabo A, Esselmann J, Hammons L, Hussain M, Ogunsesan Y, Thalambedu N, Khan F, Sethi J, Janardan A, Radhakrishnan SV, Thanendrarajan S, Schinke C, Dhakal B, Janz S, Chhabra S, D'Souza A, Zangari M, van Rhee F, Mohan M. Al Hadidi S, et al. Among authors: ogunsesan y. Bone Marrow Transplant. 2023 Apr;58(4):443-445. doi: 10.1038/s41409-022-01905-1. Epub 2022 Dec 22. Bone Marrow Transplant. 2023. PMID: 36550200 No abstract available.
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission.
Larsen K, Spencer H, Mohan M, Bailey C, Hill K, Kottarathara M, Parikh R, Hoque S, Erra A, Mitma AA, Mathur P, Yarlagadda L, Gundarlapalli S, Ogunsesan Y, Hussain M, Thalambedu N, Sehti J, Al Hadidi S, Thanendrarajan S, Graziutti M, Zangari M, Barlogie B, van Rhee F, Tricot G, Schinke C. Larsen K, et al. Among authors: ogunsesan y. J Clin Med. 2022 Mar 16;11(6):1640. doi: 10.3390/jcm11061640. J Clin Med. 2022. PMID: 35329966 Free PMC article.
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma.
Mohan M, Gundarlapalli S, Szabo A, Yarlagadda N, Kakadia S, Konda M, Jillella A, Fnu A, Ogunsesan Y, Yarlagadda L, Thalambedu N, Munawar H, Graziutti M, Al Hadidi S, Alapat D, Thanendrarajan S, Zangari M, van Rhee F, Schinke C. Mohan M, et al. Among authors: ogunsesan y. Am J Hematol. 2022 Jun 1;97(6):E195-E198. doi: 10.1002/ajh.26530. Epub 2022 Mar 21. Am J Hematol. 2022. PMID: 35285981 Free article. No abstract available.
Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
Baker D, Bimali M, Carrillo L, Sachedina A, Alapat D, Hoque MS, Kottarathara M, Parikh R, Erra A, Mitma AA, Mathur P, Ogunsesan Y, Yarlagadda L, Gundarlapalli S, Thanendrarajan S, Zangari M, Van Rhee F, Tricot G, Schinke C. Baker D, et al. Among authors: ogunsesan y. Haematologica. 2021 Dec 1;106(12):3215-3218. doi: 10.3324/haematol.2021.278779. Haematologica. 2021. PMID: 34847659 Free PMC article. No abstract available.
Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status.
Baker D, Bimali M, Carrillo L, Sachedina A, Alapat D, Hoque MS, Kottarathara M, Parikh R, Erra A, Mitma AA, Mathur P, Ogunsesan Y, Yarlagadda L, Gundarlapalli S, Thanendrarajan S, Zangari M, Van Rhee F, Tricot G, Schinke C. Baker D, et al. Among authors: ogunsesan y. Haematologica. 2021 Aug 12. doi: 10.3324/haematol.278779. Online ahead of print. Haematologica. 2021. PMID: 34382384
A Rapidly Fatal Infection With Haemophilus influenzae Serotype E Harboring bla ROB-1: The Dilemma of Safe De-escalation in the Setting of Potential Extended-Spectrum β-Lactamase Production.
Hanna J, Ogunsesan Y, Snesrud E, Maybank R, Ong A, Kwak Y, Jones A, McGann P, Lesho E. Hanna J, et al. Among authors: ogunsesan y. Open Forum Infect Dis. 2018 Nov 12;5(12):ofy302. doi: 10.1093/ofid/ofy302. eCollection 2018 Dec. Open Forum Infect Dis. 2018. PMID: 30555847 Free PMC article. No abstract available.